We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Endobronchial Ultrasound Needle Designed to Retrieve Lymph Node Cell, Tissue Samples

By HospiMedica International staff writers
Posted on 27 Feb 2014
A new endobronchial ultrasound (EBUS) needle gives physicians the ability to retrieve both cell and tissue samples from lymph nodes or tumors in the pulmonary region.

Cook Medical’s (Bloomington, IN, USA) EchoTip ProCore EBUS needle is a single-use needle that collects cell and tissue samples for the diagnosis of lung cancer and various mediastinal diseases. More...
The needle can be used for fine-needle biopsy of lesions of submucosal and extramural lesions within or adjacent to the tracheobronchial tree or gastrointestinal tract.

Prior to the availability of the EchoTip ProCore EBUS needle, tissue samples from the pulmonary area could be obtained only by surgical methods. Minimally invasive procedures could obtain cell samples only through fine needle aspiration. The EchoTip ProCore EBUS needle is designed with a core-trap technology that allows physicians to collect tissue samples through a minimally invasive procedure.

“Cook’s ProCore technology has already proven itself in the GI endoscopic ultrasound space,” said Barry Slowey, global leader of Cook Medical’s endoscopy division. “We are so pleased that physicians can now use the same technology in the pulmonary area, and we hope that this technology will aid in quick and accurate diagnosis for patients.”

Moreover, Cook recently introduced the 25-gage EchoTip Ultra endobronchial ultrasound needle, which is 33% more flexible than the 22-gage needle. This feature allows physicians to deflect the endoscope to a greater level than is possible with larger needles. The added flexibility can also allow physicians to reach more pulmonary target lesions.

Related Links:

Cook Medical



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Bipolar Coagulation Generator
Aesculap
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.